Skip to content

Clinical trials

Neurocognitive Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20172
20183
20194
20201
20211
20223
20233
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed6
Terminated6
Unknown status4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jewish General Hospital3
Sunnybrook Health Sciences Centre3
AstraZeneca2
University of Calgary2
Alzheon Inc.1
Anik Giguère1
Baycrest1
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal1
Ciusss de L'Est de l'Île de Montréal1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders24
Alzheimer Disease12
Dementia10
Mental Disorders9
Nervous System Diseases8
Cognitive Dysfunction7
Brain Diseases6
Central Nervous System Diseases6
Neurodegenerative Diseases6
Tauopathies6

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.